Hypercholesterolemia
Conditions
Keywords
high cholesterol, kefir
Brief summary
High cholesterol (a type of fat in humans blood) may be one factor that can lead to heart disease. If people have higher cholesterol, it is possible that kefir (a food similar to yogurt) may help to control blood cholesterol levels.
Detailed description
New research shows that kefir (which contains bacteria also known as microbes), similar to yogurt, may improve health by lowering cholesterol levels. Much of this research however, focuses on traditional types of kefir, which differ significantly from commercially prepared kefir with regards to the types of microbes in each kefir. Additionally, there is a lack of research looking at how commercial kefir compares to traditional kefir in its ability to improve health. This has led to the consumer being confused about the health benefits they believe they are receiving, such as reduced weight gain, and improved cholesterol levels, when they purchase and consume commercial kefir. The researchers have produced a commercially usable kefir that has the health benefits of traditional grain fermented kefir. This was accomplished with only a small subset of microbes present in the traditional kefir, leading to a much easier product to commercialize and produce. Thus, this study aims to look at whether kefir, produced in the researchers laboratory and commercially available kefir, given to males for in two separate months, results in any cholesterol lowering effects. Successful completion of this project could potentially result in the development of a new commercial kefir with health benefits that are supported by scientific research and testing. In addition, if positive results are seen, a larger study will be carried out to ensure that results of the current study are consistent for the Canadian population.
Interventions
commercial versus traditional kefir
Sponsors
Study design
Masking description
Both types of kefir will be flavoured the same, and visually look the same.
Eligibility
Inclusion criteria
1. Males, aged 18-65y 2. Moderately hypercholesterolemic adults: LDL-C between 3.2 and 4.9 mM, but otherwise healthy 3. No history of CVD, type 2 diabetes, monogenic dyslipidemia or use of medications for hyperlipidemia (including statins). 4. No dairy allergy
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Blood Lipids following provision of each type of Kefir | 4 weeks | Change in blood lipid panel (HDL, LDL, Total Cholesterol, Triglycerides) will be measured in blood samples. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fecal microbiota composition changes following the provision of each type Kefir | 4 weeks | 16SrRNA-sequencing and whole metagenome sequencing will performed to determine gut microbial community changes |
Countries
Canada